Screener
Dillards DDS Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 41.2%+1.2pp | 40.5%+0.2pp | 40.3%-0.2pp | 40.2%-0.7pp | 40%-1.2pp | |
| Net margin | 10.3%+1.6pp | 9.9%+1.2pp | 8.7%-0.3pp | 8.8%-0.6pp | 8.7%-1.0pp | |
| Returns | ||||||
| Return on equity | 33.8%+4.0pp | 33.8%+2.9pp | 31.9%-2.1pp | 29%-4.4pp | 29.8%-6.3pp | |
| Return on invested capital | 47.4%+3.5pp | 51.8%+9.5pp | 42.1%-1.9pp | 44.9%-1.9pp | 43.9%-5.4pp | |
| Efficiency | ||||||
| Asset turnover | 1.8×0.0× | 1.6×0.0× | 1.9×0.0× | 1.6×-0.1× | 1.8×-0.1× | |
| Liquidity | ||||||
| Current ratio | 3×+0.4× | 2.4×0.0× | 2.6×-0.2× | 2.2×-0.2× | 2.7×-0.5× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×-0.1× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Net debt / EBITDA | -0.5×+0.3× | -0.8×-0.2× | -0.6×-0.2× | -0.9×-0.2× | -0.8×-0.2× | |
| Valuation | ||||||
| Market capitalization | $10.1B+3.6% | $8.89B+72.0% | $9.49B+27.4% | $9.37B+55.9% | $7.29B+12.7% | |
| Price / earnings | 14.8×-2.1× | 13.5×+4.6× | 16.6×+4.1× | 16.1×+6.6× | 12.7×+2.9× | |
| Price / sales | 1.5×+0.1× | 1.3×+0.6× | 1.4×+0.3× | 1.4×+0.5× | 1.1×+0.1× | |
| Price / book | 4.8×-0.3× | 4.4×+1.6× | 5.3×+1.2× | 4.6×+1.5× | 3.8×+0.5× | |
| EV / EBITDA | 9.4×-0.9× | 8.2×+3.0× | 10.3×+2.4× | 9.7×+4.0× | 7.5×+1.6× | |
| Dividend yield | 4.8%+0.6pp | 5.5%-2.5pp | 5.1%-0.4pp | 4.4%-1.3pp | 5.7%+0.4pp |
FAQ
- Where do Dillards's ratios come from?
- Every ratio is computed from Dillards's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
